Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/28/2010WO2010123900A1 Polymeric carrier systems with multiple burst release potential
10/28/2010WO2010123845A2 Siderophore conjugate immunogenic compositions and vaccines
10/28/2010WO2010123584A2 Method for transdermal iontophoretic delivery of chelated agents
10/28/2010WO2010123564A1 Emulsions for transdermal delivery
10/28/2010WO2010123563A2 Controlled release dispensing device
10/28/2010WO2010123547A1 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
10/28/2010WO2010123472A2 Process for preparing controlled releasing parts of transdermal therapeutic systems (patch) that contain meloxicam and lornoxicam
10/28/2010WO2010123443A1 Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.
10/28/2010WO2010123349A1 System for controlled drug delivery comprising biodegradable polymer microparticles
10/28/2010WO2010123103A1 Adhesive patch-containing package bag and method for storing adhesive patch
10/28/2010WO2010122996A1 Tablet and pestles therefor
10/28/2010WO2010122694A1 Oil gel comprising reverse thread-like micelle
10/28/2010WO2010122583A2 Oral pharmaceutical compositions of acid labile substances
10/28/2010WO2010122574A2 Coated capsule
10/28/2010WO2010122494A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and mometasone, and a process to make it
10/28/2010WO2010122493A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
10/28/2010WO2010122492A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
10/28/2010WO2010122491A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
10/28/2010WO2010122478A1 A medicinal antibacterial and steroids cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122477A1 A medicinal antifungal, antibacterial and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122476A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole and mometasone, and a process to make it
10/28/2010WO2010122475A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it
10/28/2010WO2010122474A2 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122473A2 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122453A1 A medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
10/28/2010WO2010122452A1 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122442A1 Paediatric solutions comprising a beta-blocker
10/28/2010WO2010122358A2 Chewable oral delivery system
10/28/2010WO2010122356A1 Sublingual spray formulation comprising dihydroartemesinin
10/28/2010WO2010122355A1 Sublingual pharmaceutical composition comprising a neutral oil
10/28/2010WO2010122276A1 Drug delivery
10/28/2010WO2010122258A2 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of a cosmetic or pharmaceutical agent other than water
10/28/2010WO2010122246A2 Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions
10/28/2010WO2010122204A1 Polyarginine nanocapsules
10/28/2010WO2010121980A1 Use of nifuratel to treat infections caused by atopobium species
10/28/2010WO2010121762A1 Paracetamol for parenteral administration
10/28/2010WO2010121621A1 Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
10/28/2010WO2010121620A1 Particulate material for controlled release of active ingredients
10/28/2010WO2010121619A1 Chewing gum and particulate material for controlled release of active ingredients
10/28/2010WO2010121600A2 Particulate pharmaceutical composition having an opioid and an opioid antagonist
10/28/2010WO2010121503A1 Tacrolimus injection preparation
10/28/2010WO2010121487A1 Preparation and use of novel antibiotic, anticancer compounds and derivatives thereof
10/28/2010WO2010121455A1 A drug composition for treating tumor with polymeric micelle encapsulating antineoplastic
10/28/2010WO2010121404A1 Bear bile extract and preparation method and use thereof
10/28/2010WO2010121368A1 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
10/28/2010WO2010121334A1 Active substances-carrying pharmaceutical composition
10/28/2010WO2010121328A1 A novel formulation of indomethacin
10/28/2010WO2010121327A1 A novel formulation of diclofenac
10/28/2010WO2010121326A1 A novel formulation of naproxen
10/28/2010WO2010121325A1 A novel formulation of meloxicam
10/28/2010WO2010121324A1 A novel formulation of metaxalone
10/28/2010WO2010121323A1 Method for the production of commercial nanoparticle and microparticle powders
10/28/2010WO2010121322A1 Production of encapsulated nanoparticles at commercial scale
10/28/2010WO2010121321A1 Method for improving the dissolution profile of a biologically active material
10/28/2010WO2010121320A1 Production of encapsulated nanoparticles at high volume fractions
10/28/2010WO2010121285A1 Dosing
10/28/2010WO2010100514A3 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure
10/28/2010WO2010097814A3 A controlled release micro-capsule for osteogenic action
10/28/2010WO2010093941A3 COMPOSITIONS AND METHODS FOR MINIMALLY-INVASIVE SYSTEMIC DELIVERY OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS
10/28/2010WO2010093925A3 Peripheral administration of proteins including tgf-beta superfamily members for systemic treatment of disorders and disease
10/28/2010WO2010084397A8 Modified release solid pharmaceutical compositions of trimetazidine and process thereof
10/28/2010WO2010082214A3 Fenofibrate formulation with enhanced oral bioavailability
10/28/2010WO2010080977A3 Oral sustained release antidepressant formulation
10/28/2010WO2010080765A3 High-throughput production of ingestible event markers
10/28/2010WO2010078045A3 Method of making small liposomes
10/28/2010WO2010070665A3 A process for nanoemulsification of curcumin and derivatives of curcumin
10/28/2010WO2010068754A3 Methods and compositions for delivery of medicaments to the lungs
10/28/2010WO2010061288A3 Polymeric pharmaceutical dosage form in sustained release
10/28/2010WO2010061284A3 A controlled release intravaginal polymeric pharmaceutical dosage form
10/28/2010WO2009150530A3 Pharmaceutical composition suitable for use as foam comprising 5'-aminosalicylic acid and silicone oil
10/28/2010WO2009147372A3 Drug delivery composition
10/28/2010WO2009143175A3 Sensory-specific local anesthesia and prolonged duration local anesthesia
10/28/2010WO2009141321A3 Tablettable chewing gums comprising nicotine and a buffering agent
10/28/2010WO2009135951A3 Process for preparing a tablet comprising metformin
10/28/2010WO2009135950A3 Process for preparing a tablet containing excipients
10/28/2010WO2009135949A3 Process for preparing a very high drug load tablet
10/28/2010WO2009133352A3 Lipid composition
10/28/2010WO2009130265A3 Medical device
10/28/2010WO2009106997A9 Amorphous arformoterol l-(+)-tartrate
10/28/2010US20100274362 Cartilage particle tissue mixtures optionally combined with a cancellous construct
10/28/2010US20100274176 Wound care system and bactericidal methods and devices
10/28/2010US20100273990 Notch-based fusion proteins and uses thereof
10/28/2010US20100273884 Method for stable and controlled delivery of (-)-hydroxycitric acid
10/28/2010US20100273882 Use of adapalene gel or cream
10/28/2010US20100273828 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273752 Mequitazine for treating or preventing pathologies involving histamine h4 receptors
10/28/2010US20100273730 Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
10/28/2010US20100272860 Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272822 Nanocell drug delivery system
10/28/2010US20100272820 Preparation Method of Sustained-Release Microcapsules Having Good Initial Burst Inhibiting Property and the Microcapsules Thereby
10/28/2010US20100272819 Production of cellulose nanoparticles
10/28/2010US20100272818 Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
10/28/2010US20100272817 Compositions and Methods for Treating Atherosclerosis
10/28/2010US20100272816 Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
10/28/2010US20100272815 Amorphous form of tapentadol hydrochloride
10/28/2010US20100272814 Method and means for producing bronchorelaxation
10/28/2010US20100272813 Nanoparticle-mediated treatment for inflammatory diseases
10/28/2010US20100272812 Rgd-modified alginate microparticles as a drug release system
1 ... 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 ... 2991